Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipiodal for Free Flap Sparing Radiation Planning in Head and Neck Cancer
NCT06806189Phase 1Not yet recruiting
- Sponsor
- Western University
- Start
- Apr 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ethiodized oil in oral cavity squamous cell carcinoma (OCSCC), sponsored by Western University. Primary endpoints: Success of intra-operative injection and Success of visualisation on immediate post-operative and adjuvant radiation planning CT scans. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
ethiodized oil
03
Conditions
oral cavity squamous cell carcinoma (OCSCC)
Beyond the preview
Go deeper on NCT06806189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06806189.